Science
Mechanism of Action
Functions as a lipophilic prodrug that penetrates the pilosebaceous unit more effectively than standard ALA. Once absorbed, cellular enzymes convert it to protoporphyrin IX through the heme synthesis pathway. Light exposure at 415nm (blue) or 630nm (red) wavelengths activates the accumulated protoporphyrin IX, generating reactive oxygen species that selectively eliminate C. acnes bacteria and trigger controlled sebaceous gland atrophy.
Research
Clinical Evidence
Medium confidence1.5%
Transparency
Dusting Analysis
Requires precise dosing at 1.5% for therapeutic efficacy; concentrations below 1% likely provide minimal photodynamic benefit
The Formula
Formulation
Stability
Requires acidic pH environment to prevent ester bond hydrolysis. Extremely photosensitive and demands light-protective packaging. Hydrochloride salt form enhances aqueous solubility.
Synergies
- Blue light therapy
- Red light therapy
- Acidic pH buffers
Conflicts
- Alkaline ingredients
- Strong oxidizing agents
- Metal ions
Safety
Safety Profile
Parent compound ALA is FDA-approved for medical PDT, but butenyl derivative lacks formal regulatory safety assessment. Primarily used in South Korean cosmetic markets.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Clinically proven acne treatment with superior penetration properties, though limited by regulatory uncertainty and formulation complexity.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources